Skip to main content

Peer Review reports

From: FDC-SP as a diagnostic and prognostic biomarker and modulates immune infiltrates in renal cell carcinoma

Original Submission
22 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Dec 2022 Reviewed Reviewer Report
17 Dec 2022 Reviewed Reviewer Report - Qingshi Wang
8 Feb 2023 Author responded Author comments - Fangmin Chen
Resubmission - Version 3
8 Feb 2023 Submitted Manuscript version 3
13 Feb 2023 Author responded Author comments - Fangmin Chen
Resubmission - Version 4
13 Feb 2023 Submitted Manuscript version 4
14 Feb 2023 Author responded Author comments - Fangmin Chen
Resubmission - Version 5
14 Feb 2023 Submitted Manuscript version 5
25 Feb 2023 Reviewed Reviewer Report
28 Feb 2023 Reviewed Reviewer Report - Qingshi Wang
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
1 Mar 2023 Editorially accepted
10 Mar 2023 Article published 10.1186/s12859-023-05215-1

You can find further information about peer review here.

Back to article page